JCK-AP session 4 (II-JCKAP4)
Fontan

[II-JCKAP4-5] Phase 2 Open-label, Single-arm, Multi-center Clinical Trial of Camostate Mesylate in Patients with Protein-losing Enteropathy after Fontan Operation

^○Woo Young Park¹, Gi Beom Kim¹, Sang Yun Lee¹, Jae Suk Baek², Soo Jin Kim³, Jowon Jung⁴, Myung Chul Hyun⁵, Young Tae Lim⁵, Joowon Lee⁶ (1.Department of Pediatrics, Seoul National University Children's Hospital, Seoul, 2.Department of Pediatrics, Asan Medical Center Children's Hospital, Ulsan University College of Medicine, Seoul, 3.Department of Pediatrics, Sejong General Hospital, Bucheon, 4.Department of Pediatrics, Yonsei University College of Medicine, Seoul, 5.Department of Pediatrics, Kyungpook National University Hospital, Daegu, 6.Department of Pediatrics, Seoul National University Bundang Hospital, Seongnam)

キーワード：Camostat mesylate, protein-losing enteropathy, Fontan operation